Parents
Sign in to add mentor| Henry S. Kaplan | grad student | Stanford University Medical School | |
| Saul A. Rosenberg | grad student | Stanford University Medical School |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Morden JP, Alvarez I, Bertelli G, et al. (2017) Long-Term Follow-Up of the Intergroup Exemestane Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016705640 |
| Blum JL, Flynn PJ, Yothers G, et al. (2017) Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016714147 |
| Finn RS, Martin M, Rugo HS, et al. (2016) Palbociclib and Letrozole in Advanced Breast Cancer. The New England Journal of Medicine. 375: 1925-1936 |
| O'Shaughnessy JA, Koeppen H, Xiao Y, et al. (2015) Patients with Slowly Proliferative Early Breast Cancer have Low 5-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Jones SE, Collea R, Paul D, et al. (2013) Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. The Lancet. Oncology. 14: 1121-8 |
| Jacquin JP, Jones S, Magné N, et al. (2012) Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials. Breast Cancer Research and Treatment. 134: 903-13 |
| Hezewijk Mv, Hille ETM, Putter H, et al. (2012) 391 Higher Risk of Locoregional Recurrences for Women Treated with Mastectomy Compared to Breast-Conserving Therapy in Postmenopausal Women with Early Breast Cancer Treated on the TEAM Trial European Journal of Cancer. 48 |
| Water Wvd, Bastiaannet E, Seynaeve C, et al. (2012) 22 Increased Breast Cancer Recurrence in Elderly Patients is Explained by a Higher Risk of Distant Recurrence – a TEAM Study Analysis European Journal of Cancer. 48 |
| Fontein D, Hadji P, Seynaeve C, et al. (2012) 87. Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors – A TEAM trial analysis Ejso. 38: 758-759 |
| Loesch D, Robert N, Jones S, et al. (2011) Phase II Trial of a Novel Paclitaxel Schedule As Single-Agent, First-Line Therapy for HER-2/neu-Negative Metastatic Breast Cancer: A Community-Based Study. Journal of Oncology Practice. 2: 268-73 |